FDA product code ORW: N95 Respirator With Antimicrobial/Antiviral Agent For Use By The General Public In Public Health Medical Emergencies

ORW is the FDA product code for n95 respirator with antimicrobial/antiviral agent for use by the general public in public health medical emergencies. It is a Class II device, regulated under 21 CFR 880.6260 and reviewed by the General Hospital panel. FDA has cleared 1 510(k) submission under ORW. The average 510(k) review took 266 days (median 266).

Definition

A single use, disposable, NIOSH-approved N95 respirator intended for use by the general public in public health medical emergencies to cover the nose and mouth of the wearer to help reduce wearer exposure to pathogenic biological particulates and has an added antimicrobial and/or antiviral agent which kills specified pathogens under specified contact conditions.

Classification

FieldValue
Device nameN95 Respirator With Antimicrobial/Antiviral Agent For Use By The General Public In Public Health Medical Emergencies
Device classClass II
Regulation21 CFR 880.6260
Review panelHO — General Hospital
Medical specialtyGeneral Hospital
Premarket route510(k)

Compare with all 510(k) review times · Search every ORW clearance

Top ORW applicants

ApplicantClearancesLatest
Glaxosmithkline Consumer Healthcare12010-07-02

Most recent ORW clearances

510(k)ApplicantDeviceDecision dateReview days
K093189Glaxosmithkline Consumer HealthcareACTIPROTECT UC N95 RESPIRATOR2010-07-02266

Recalls for ORW devices

openFDA lists no recalls for product code ORW.

Frequently asked questions

What is FDA product code ORW?

ORW is the FDA product code for n95 respirator with antimicrobial/antiviral agent for use by the general public in public health medical emergencies. It is a Class II device, regulated under 21 CFR 880.6260 and reviewed by the General Hospital panel.

What device class is ORW?

Class II, regulation 21 CFR 880.6260. Typical premarket route: 510(k).

How long does a 510(k) take for product code ORW?

Across 1 cleared submissions the average was 266 days from receipt to decision (median 266).

Which companies have the most ORW clearances?

Glaxosmithkline Consumer Healthcare (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All General Hospital product codes · FDA product code lookup · 510(k) database search · 510(k) review times